{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T17:47:57Z","timestamp":1776188877961,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jaip.2018.12.021","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T17:49:07Z","timestamp":1547142547000},"page":"1488-1496.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Assessment of Adherence and Asthma Medication Ratio for a Once-Daily and Twice-Daily Inhaled Corticosteroid\/Long-Acting \u03b2-Agonist for Asthma"],"prefix":"10.1016","volume":"7","author":[{"given":"Richard H.","family":"Stanford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlyne","family":"Averell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily D.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cori","family":"Blauer-Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler K.","family":"Reinsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ami R.","family":"Buikema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2018.12.021_bib2","author":"Blackwell"},{"key":"10.1016\/j.jaip.2018.12.021_bib3","author":"Bloom"},{"key":"10.1016\/j.jaip.2018.12.021_bib4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jaci.2010.10.042","article-title":"The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey","volume":"127","author":"Sullivan","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.12.021_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaci.2010.10.020","article-title":"Costs of asthma in the United States: 2002-2007","volume":"127","author":"Barnett","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.12.021_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jaip.2013.11.013","article-title":"Clinical burden and predictors of asthma exacerbations in patients on guideline-based steps 4-6 asthma therapy in the TENOR cohort","volume":"2","author":"Calhoun","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.12.021_bib7","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jaci.2012.01.039","article-title":"Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma","volume":"129","author":"Ivanova","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.12.021_bib8","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1185\/03007995.2011.557717","article-title":"Uncontrolled persistent allergic asthma in practice: eXpeRience registry baseline characteristics","volume":"27","author":"Braunstahl","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaip.2018.12.021_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2500\/aap.2009.30.3276","article-title":"The status of asthma control in the U.S. adult population","volume":"30","author":"Fuhlbrigge","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2018.12.021_bib10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3109\/02770903.2013.795589","article-title":"Asthma control, cost and race: results from a national survey","volume":"50","author":"Gold","year":"2013","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.jaip.2018.12.021_bib11","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1185\/03007990802557344","article-title":"Association between adherence with fixed dose combination fluticasone propionate\/salmeterol on asthma outcomes and costs","volume":"24","author":"Delea","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaip.2018.12.021_bib12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.anai.2012.08.014","article-title":"Short acting \u03b2-agonist use and its ability to predict future asthma-related outcomes","volume":"109","author":"Stanford","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.12.021_bib14","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1378\/chest.128.4.1968","article-title":"Asthma quality-of-care markers using administrative data","volume":"128","author":"Schatz","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2018.12.021_bib15","first-page":"327","article-title":"Relationship of asthma control to asthma exacerbations using surrogate markers within a managed care database","volume":"16","author":"Schatz","year":"2010","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jaip.2018.12.021_bib16","first-page":"60","article-title":"Predicting asthma outcomes in commercially insured and Medicaid populations?","volume":"19","author":"Stanford","year":"2013","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jaip.2018.12.021_bib17","series-title":"Symbicort 160\/4.5 (budesonide 160 mcg and formoterol fumarate dehydrate 4.5 mcg) Inhalation aerosol [package insert]","year":"2010"},{"key":"10.1016\/j.jaip.2018.12.021_bib18","series-title":"Breo Ellipta (fluticasone furoate and vilanterol inhalation powder) [package insert]","year":"2017"},{"key":"10.1016\/j.jaip.2018.12.021_bib19","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/MLR.0b013e31829b1d2a","article-title":"Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases","volume":"51","author":"Raebel","year":"2013","journal-title":"Med Care"},{"key":"10.1016\/j.jaip.2018.12.021_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.jaip.2018.12.021_bib21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jaip.2018.12.021_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2466-10-1","article-title":"Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study","volume":"10","author":"Price","year":"2010","journal-title":"BMC Pulmon Med"},{"key":"10.1016\/j.jaip.2018.12.021_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jval.2011.01.001","article-title":"Treatment with inhaled mometasone furoate reduces short-acting beta2 agonist claims and increases adherences compared to fluticasone propionate in asthma patients","volume":"14","author":"Navaratnam","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.jaip.2018.12.021_bib24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.anai.2013.06.008","article-title":"Real-world effects of once vs greater daily inhaled corticosteroid dosing on medication adherence","volume":"111","author":"Wells","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.12.021_bib25","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2006.06.034","article-title":"Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma","volume":"118","author":"Marceau","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.12.021_bib26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/pds.1552","article-title":"Treatment with inhaled corticosteroids in asthma is too often discontinued","volume":"17","author":"Breekveldt-Postma","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaip.2018.12.021_bib27","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1081-1206(10)60286-4","article-title":"Relationship between recent short-acting \u03b2-agonist use and subsequent asthma exacerbations","volume":"101","author":"Paris","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.12.021_bib28","first-page":"1014","article-title":"Use of ICS\/LABA on asthma exacerbation risk in patients within a medical group","volume":"21","author":"Stanford","year":"2015","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.jaip.2018.12.021_bib29","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jaci.2006.07.002","article-title":"Adherence and persistence with fluticasone propionate\/salmeterol combination therapy","volume":"118","author":"Bender","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.12.021_bib30","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1164\/rccm.200808-1233OC","article-title":"Race-ethnic differences in factors associated with inhaled steroid adherence among adults with asthma","volume":"178","author":"Wells","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2018.12.021_bib31","first-page":"208","article-title":"Development and preliminary validation of the adult asthma adherence questionnaire","volume":"1","author":"Schatz","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.12.021_bib32","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/1475-6773.12043","article-title":"Potential bias in medication adherence studies of prevalent users","volume":"48","author":"Maciejewski","year":"2013","journal-title":"Health Serv Res"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219819300017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219819300017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:20:15Z","timestamp":1761974415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219819300017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2213219819300017"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2018.12.021","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of Adherence and Asthma Medication Ratio for a Once-Daily and Twice-Daily Inhaled Corticosteroid\/Long-Acting \u03b2-Agonist for Asthma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2018.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}